| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 06/24/2009 | EP2073060A1 Novel compound and method of producing the same, acid generator, resist composition and method of forming resist pattern |
| 06/24/2009 | EP1781614B1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 06/24/2009 | EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 06/24/2009 | EP1153047B1 Metallocene compounds, process for their preparation and their use in catalytic systems for the polymerization of olefins |
| 06/24/2009 | CN101463029A Taxane derivative, and preparation and use thereof |
| 06/24/2009 | CN100503595C Second-order non-linear optical polymer containing azo and thiophene ring, and its synthesizing method and use |
| 06/24/2009 | CN100503594C Sterilization composition and preparation method thereof |
| 06/23/2009 | US7550605 Process for preparation of (+-)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, comprising racemization of (R)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine by treatment with a base |
| 06/23/2009 | US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride |
| 06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/23/2009 | US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
| 06/18/2009 | WO2009075291A1 Optically active dinickel complex and method for producing optically active amine using the optically active dinickel complex as catalyst |
| 06/18/2009 | WO2009074789A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors |
| 06/18/2009 | WO2009074741A2 Novel method for the synthesis of strontiuim ranelate and of hydrates thereof |
| 06/18/2009 | WO2009021126A3 Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group |
| 06/18/2009 | US20090156833 Process for the Preparation of Enantiomerically Pure 1-Substituted-3-Aminoalcohols |
| 06/18/2009 | US20090156805 Cycloalkane Carboxamide Derivatives and Production Process of Same |
| 06/18/2009 | US20090156685 (r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
| 06/18/2009 | US20090156651 Heterocyclylethylbenzamide Derivatives |
| 06/18/2009 | US20090156591 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors |
| 06/17/2009 | EP2069323A1 Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide |
| 06/17/2009 | EP2069322A2 Thiophene derivatives as s1p1/edg1 receptor agonists |
| 06/17/2009 | EP2069295A2 Substituted cyclopentane derivatives as therapeutic agents |
| 06/17/2009 | EP2069289A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 06/17/2009 | EP2069287A1 Insecticidal compounds |
| 06/17/2009 | EP2069286A1 Inhibitors for glyt-1 |
| 06/17/2009 | EP1836166B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | EP1383736B1 Peptide deformylase inhibitors |
| 06/17/2009 | EP1322592B2 Substituted 1-aminobutan-3-ol derivatives |
| 06/17/2009 | CN100500679C Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/16/2009 | US7547725 Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
| 06/16/2009 | US7547701 cathepsin S inhibitors; e.g. N-(1-cyanocyclopropyl)-3-phenylmethanesulfonyl-2-(2,2,2-trifluoro-1-phenylethylamino)-propionamide; autoimmune diseases such as rheumatoid arthritis or multiple sclerosis, pain, or atherosclerosis |
| 06/16/2009 | CA2447640C Substituted anilide derivative, intermediate thereof, agricultural and horticultural chemical and its usage |
| 06/16/2009 | CA2202032C Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
| 06/11/2009 | WO2009073432A1 Substituted cyclopentanes having prostaglandin activity |
| 06/11/2009 | WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | WO2009070873A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |
| 06/11/2009 | WO2009008920A3 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning |
| 06/11/2009 | WO2002065984A3 Compounds having retinoid-like activity |
| 06/11/2009 | US20090149677 Stereoselective Method for the Production of (R)-Dimepranol |
| 06/11/2009 | US20090149548 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149444 Benzylamine analogues |
| 06/11/2009 | CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | CA2706879A1 Substituted cyclopentanes having prostaglandin activity |
| 06/11/2009 | CA2706632A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |
| 06/10/2009 | EP2068379A1 Organic semiconductor material, organic semiconductor device using the same, and their production methods |
| 06/10/2009 | EP2067782A1 Heteroacene derivative, tetrahaloterphenyl derivative, and their production methods |
| 06/10/2009 | EP2066620A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 06/10/2009 | EP2066615A2 Cyclopentane derivatives as antiglaucoma agents |
| 06/10/2009 | EP1532105B1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 06/10/2009 | EP1530470B1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | CN101454306A Process for preparing duloxetine and intermediates thereof |
| 06/10/2009 | CN100497330C Thiophene-2,5-dicarboxylic acid synthesis method |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100497295C Process for the preparation of N-monosubstituted beta-amino alcohols |
| 06/09/2009 | US7544721 Photosensitive adhesive composition |
| 06/09/2009 | US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes |
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544690 MCH receptor antagonists |
| 06/09/2009 | CA2251331C Calcilytic compounds |
| 06/04/2009 | WO2009069687A1 Conjugated compound, nitrogenated condensed-ring compound, nitrogenated condensed-ring polymer, organic thin film, and organic thin film element |
| 06/04/2009 | WO2009069602A1 Benzanthracene compound and organic electroluminescent device using the same |
| 06/04/2009 | WO2009069537A1 Light-emitting device material and light-emitting device |
| 06/04/2009 | WO2009069428A1 Photoacid generator and photoreactive composition |
| 06/04/2009 | WO2009068520A2 Polymorphic form of rotigotine |
| 06/04/2009 | US20090143600 reacting N,N-dimethyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine with tartaric acid, crytallization of the diastereoisomer which yields, in reaction with an inorganic or organic base, (S)-N,N-dimethyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine, demethylation using alkylchloroformate, then hydrolyzing |
| 06/04/2009 | US20090143599 Heterocyclic Fused Selenophene Monomers |
| 06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
| 06/04/2009 | US20090143461 Substituted cyclopentanes having prostaglandin activity |
| 06/04/2009 | US20090143460 Novel polymorphic form of rotigotine and process for production |
| 06/04/2009 | US20090143411 Thiophens and Their Use as Anti-Tumor Agents |
| 06/04/2009 | CA2703561A1 Novel polymorphic form of rotigotine and process for production |
| 06/03/2009 | EP2064198A2 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 06/03/2009 | EP2064194A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 06/03/2009 | EP2064177A2 Protease inhibitors |
| 06/03/2009 | EP1786790B1 Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
| 06/03/2009 | EP1330458B1 N-( 1,2,4 triazoloazinyl) thiophenesulfonamide compounds as herbicides |
| 06/03/2009 | CN101448815A Duloxetine HCI polymorphs |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/02/2009 | US7541425 Mono-, oligo- and poly(3-alkynylthiophenes) and their use as charge transport materials |
| 06/02/2009 | US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases |
| 06/02/2009 | US7541381 Sulfur compounds such as 3-((4-chloroanilino)sulfonyl)thio-phene-2-carboxylic acid, used as enzymes inhibitors for prophylaxis of antibiotic resistant bacterial infections |
| 06/02/2009 | CA2442875C New process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts ofranelic acid and their hydrates |
| 06/02/2009 | CA2436185C Method for obtaining 4-(n-alkylamine)-5, 6-dihydro-4h-thieno-(2,3-b)-thiopyran-2-sulfamide-7, 7-dioxides and intermediate products |
| 05/28/2009 | WO2009066060A2 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use |
| 05/28/2009 | WO2009049180A3 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 05/28/2009 | WO2009030467A3 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 05/28/2009 | US20090137823 (E)-N-Monoalkyl-3-Oxo-3-(2-Thienyl) Propenamine and Process for Producing the Same and Process for Producing (E,Z)-N-Monoalkyl-3-Oxo-3-(2-Thienyl) Propenamine |
| 05/28/2009 | US20090137822 Process for preparing 3-substituted thiophene |
| 05/28/2009 | US20090137799 Cycloalkylcarbonylamino Acid Ester Derivative and Process for Producing The Same |
| 05/28/2009 | US20090137659 Compounds that modulate intracellular calcium |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
| 05/28/2009 | US20090136979 Class IIA Histone Deacetylase (HDAC) Substrate |